LEMAITRE VASCULAR INC

LMAT · XNAS

CIK 1158895fmd_1W0JV3GJBJNYBHNMVYSFZ6VXCFManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	89	101	106	117	129	154	162	193	220	250
Cost of revenue	26	30	32	37	45	53	57	66	69	71
Gross profit	63	71	74	80	85	101	105	127	151	179
Research and development	6	7	8	9	10	12	13	17	16	14
Selling, general and administrative	40	43	45	49	46	53	62	73	83	96
Total operating expenses	47	50	46	59	56	65	78	90	99	111
Operating income	16	21	28	21	29	36	27	37	52	68
Interest expense	0	0	0	0	1	2	0	0	0	5
Interest and investment income	0	0	1	1	0	0	1	3	5	13
Other non-operating income (expense)	–	–	–	–	(0)	(0)	(0)	(0)	(0)	(1)
Income before taxes	16	21	28	22	27	34	27	39	57	75
Income tax expense	6	4	6	4	6	7	7	9	13	17
Net income from continuing operations	11	17	23	18	21	27	21	30	44	58
Net income	11	17	23	18	21	27	21	30	44	58